These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1526678)

  • 1. Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.
    Gialdroni Grassi G; Shah PM
    Infection; 1992; 20 Suppl 1():S51-3. PubMed ID: 1526678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cefodizime on non-specific immune functions in patients with multiple myeloma.
    Dammacco F; Benvestito S
    Infection; 1992; 20 Suppl 1():S64-6. PubMed ID: 1526682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cefodizime on the reagibility of human leukocytes.
    Limbert M; Müllner H; Shah PM
    Infection; 1992; 20 Suppl 1():S48-50. PubMed ID: 1388140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological evaluation of cefodizime: a unique molecule among cephalosporins.
    Labro MT
    Infection; 1992; 20 Suppl 1():S45-7. PubMed ID: 1526677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cefodizime on parameters of cell-mediated immunity in vitro.
    Mallmann P; Brühl P; Dagrosa EE; Reeves A
    Arzneimittelforschung; 1992 Apr; 42(4):567-70. PubMed ID: 1642684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system.
    Limbert M; Bartlett RR; Dickneite G; Klesel N; Schorlemmer HU; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Dec; 37(12):1719-26. PubMed ID: 6098573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopharmacological activity of cefodizime in young and elderly subjects: in vitro and ex vivo studies.
    Meroni PL; Capsoni F; Borghi MO; Barcellini W; Minonzio F; Ongari AM; Fain C; Hu C; Brambilla G; Pettenati C
    Infection; 1992; 20 Suppl 1():S61-3. PubMed ID: 1526681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
    Shin WS; Min CK; Kim YR; Yoo JH; Kang MW
    J Antimicrob Chemother; 1996 Jan; 37(1):93-103. PubMed ID: 8647779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
    Fietta A; Bersani C; Bertoletti R; Grassi FM; Grassi GG
    Chemotherapy; 1988; 34(5):430-6. PubMed ID: 3053065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
    McCafferty AC; McGregor E; Jones M; Henderson IS; Cree IA
    Int J Clin Lab Res; 1996; 26(4):229-35. PubMed ID: 9007612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cefodizime (HR 221) on immunological defects induced by surgical stress.
    Auteri A; Pasqui AL; Bruni F; Saletti M; Mazza S; Di Renzo M; Maggiore D; Di Perri T
    Drugs Exp Clin Res; 1991; 17(12):555-61. PubMed ID: 1841048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration.
    Dagrosa EE; Hajdú P; Malerczyk V; de Looze S; Seeger K; Grötsch H
    Clin Ther; 1987; 10(1):18-31. PubMed ID: 3450392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cefodizime and cefotaxime on cellular and humoral immune responses.
    Pulverer G
    Infection; 1992; 20 Suppl 1():S41-4. PubMed ID: 1526676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties.
    Labro MT
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():37-47. PubMed ID: 2074251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia.
    Carandente F; De Vecchi A; Halberg F; Cornélissen G; Dammacco F
    Chronobiologia; 1988; 15(1-2):61-85. PubMed ID: 3262046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefodizime, a new 2-aminothiazolyl cephalosporin: physicochemical properties, toxicology and structure-activity relationships.
    Bryskier A; Procyk T; Labro MT
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():1-8. PubMed ID: 2074243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
    Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
    Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
    Labro MT; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
    Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
    Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulatory effect of cefodizime on macrophage-mediated phagocytosis.
    Oishi K; Matsumoto K; Yamamoto M; Morito T; Yoshida T
    J Antibiot (Tokyo); 1989 Jun; 42(6):989-92. PubMed ID: 2737956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.